A prospective study of antenatal SARS-CoV-2 BNT162b2 mRNA vaccination for maternal and neonatal protection from COVID-19
Latest Information Update: 23 Feb 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 16 Feb 2022 Results assessing the effect of gestational age at the time of SARS-CoV-2 vaccination on maternal antibody levels and transplacental antibody transfer has important implications for maternal care and vaccination strategies, published in the Clinical Infectious Diseases.
- 15 Apr 2021 New trial record
- 03 Apr 2021 Results published in the Clinical Infectious Diseases.